Vanguard Group’s Context Therapeutics CNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.2M | Buy |
|
|||||
|
2025
Q1 | $1.99M | Sell |
|
|||||
|
2024
Q4 | $3.42M | Sell |
|
|||||
|
2024
Q3 | $7.34M | Sell |
|
|||||
|
2024
Q2 | $9.03M | Buy |
|
|||||
|
2024
Q1 | $826K | Buy |
|
|||||
|
2023
Q4 | $673K | Buy |
|
|||||
|
2023
Q3 | $896K | Buy |
|
|||||
|
2023
Q2 | $920K | Buy |
|
|||||
|
2023
Q1 | $322K | Sell |
|
|||||
|
2022
Q4 | $418K | Buy |
|
|||||
|
2022
Q3 | $711K | Buy |
|
|||||
|
2022
Q2 | $1.33M | Buy |
|
|||||
|
2022
Q1 | $513K | Buy |
|
|||||
|
2021
Q4 | $571K | Buy |
|